Compare RMBS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMBS | ITGR |
|---|---|---|
| Founded | 1990 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 3.0B |
| IPO Year | 1997 | 2000 |
| Metric | RMBS | ITGR |
|---|---|---|
| Price | $94.03 | $85.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $108.17 | $91.14 |
| AVG Volume (30 Days) | ★ 1.6M | 741.0K |
| Earning Date | 04-27-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.88 | N/A |
| EPS | 2.11 | ★ 2.89 |
| Revenue | $707,630,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $15.74 | $1.69 |
| Revenue Next Year | $16.56 | $6.53 |
| P/E Ratio | $43.19 | ★ $29.15 |
| Revenue Growth | ★ 27.13 | 7.98 |
| 52 Week Low | $40.12 | $62.00 |
| 52 Week High | $135.75 | $127.56 |
| Indicator | RMBS | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 51.73 |
| Support Level | $91.98 | $82.78 |
| Resistance Level | $100.01 | $88.36 |
| Average True Range (ATR) | 4.22 | 2.73 |
| MACD | 0.62 | -0.05 |
| Stochastic Oscillator | 73.08 | 44.13 |
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.